Award notice
PREVENT IDIQ MATO RFP
75N91024D00006
National Institutes of Health, NIH NCI. Research and Development in Biotechnology (except Nanobiotechnology).
Awarded
Weill Medical College of Cornell University
$149,995,000.00 on the award notice, January 24, 2024, contract 75N91024D00006
Description
As published on SAM.gov.
PREVENT EFFICACY Pool: This contract supports the PREVENT Cancer Preclinical Drug Development Program, which provides a structured approach to drug and vaccine development, from discovery to the clinic. This contract is a part of a multiple-award Indefinite Delivery Indefinite Quantity (IDIQ) pool to procure services related to Preclinical Efficacy and Intermediate Endpoint Biomarkers, which is also referred to as the Efficacy Pool.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- UEI
- YNT8TCJH8FQ8
- CAGE
- 1UMU6
- Vendor location
- New York, NY
- Contract
- 75N91024D00006
- Obligated
- $0.00, potential $149,995,000
- Actions
- 5 between January 24, 2024 and August 31, 2026
- Competition
- Full and Open Competition, 9 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- Preclinical Efficacy & Intermediate Endpoint Biomarkers IDIQ Contract in Support of the Prevent Cancer Preclinical Drug Development Program
- Match
- award number 75N91024D00006 equals the contract number; same awarding office 75N910 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
January 29, 2024
Award notice, originally solicitation
Awarded to WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY New York for $149,995,000. SAM.gov, notice a09e3ba579a54a8c8a4ae3948f2d57ae
January 31, 2024
Award notice
Awarded to WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY New York for $149,995,000. SAM.gov, notice 4b33173492c44fccabbf0b4128412ae1
Points of contact
- TAYLOR, RICHARDrich.taylor@nih.gov+1 717 339 9735
Also open from this buyer
- NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAMSolicitationSmall businessNAICS 5417175N98026R00109Closes in 4 daysSep 21